Sensus Healthcare Completes Installation of its First SRT System in Ireland
Delivery of the SRT-100 marks the expansion of radiotherapy services at Dublin’s Beacon Hospital Non-melanoma skin cancer affects more than 12,000 patients in Ireland annually BOCA RATON, Fla., July 25, 2023 — Sensus Healthcare, Inc. (Nasdaq: SRTS), a medical device company specializing in highly effective, non-invasive, minimally-invasive and cost-effective treatments for oncological and non-oncological conditions, […]
Sensus Healthcare Partners with MIS Healthcare to Distribute SRT Systems in the United Kingdom and Ireland
Full line of Sensus’ SRT products for the non-invasive treatment of non-melanoma skin cancer and keloids now available to MIS Healthcare customers BOCA RATON, Fla, July 06, 2023 — Sensus Healthcare, Inc. (Nasdaq: SRTS), a medical device company specializing in highly effective, non-invasive, minimally-invasive and cost-effective treatments for oncological and non-oncological conditions, announces a partnership […]
Sensus Healthcare to Participate in the Maxim Group Virtual Healthcare Conference Hosted by M-Vest
BOCA RATON, Fla, June 15, 2023 — Sensus Healthcare, Inc. (Nasdaq: SRTS), a medical device company specializing in highly effective, non-invasive, minimally-invasive and cost-effective treatments for oncological and non-oncological conditions, announces its participation in the Maxim Group Virtual Healthcare Conference hosted by M-Vest. Joe Sardano, Chairman and Chief Executive Officer, Michael Sardano, President and General […]
Sensus Healthcare to Participate in the Maxim Group Virtual Healthcare Conference Hosted by M-Vest
BOCA RATON, Fla, June 15, 2023 — Sensus Healthcare, Inc. (Nasdaq: SRTS), a medical device company specializing in highly effective, non-invasive, minimally-invasive and cost-effective treatments for oncological and non-oncological conditions, announces its participation in the Maxim Group Virtual Healthcare Conference hosted by M-Vest. Joe Sardano, Chairman and Chief Executive Officer, Michael Sardano, President and General […]
Sensus Healthcare’s SRT Treatment Shows Promise in Treating Cutaneous Mast Cell Tumors Among Pet Patients
BOCA RATON, Fla, May 17, 2023 — Sensus Healthcare Inc. (Nasdaq:SRTS), the leading manufacturer of advanced medical devices for non-surgical skin cancer and keloid scar treatment, is announcing that its superficial radiation therapy SRT-100 system has shown promising results treating Cutaneous Mast Cell Tumors (MCTs) in pets. This new limited study, just published in the […]
Sensus Healthcare’s SRT Treatment Shows Promise in Treating Cutaneous Mast Cell Tumors Among Pet Patients
BOCA RATON, Fla, May 17, 2023 — Sensus Healthcare Inc. (Nasdaq:SRTS), the leading manufacturer of advanced medical devices for non-surgical skin cancer and keloid scar treatment, is announcing that its superficial radiation therapy SRT-100 system has shown promising results treating Cutaneous Mast Cell Tumors (MCTs) in pets. This new limited study, just published in the […]
Sensus Healthcare Reports First Quarter 2023 Financial Results
Lower demand for SRT systems reflects the impact of inflation on dermatologists’ cash flow from fewer elective aesthetic procedures and higher operating costs Sensus expects to ship more than 60 SRT units during 2023 and return to profitability in the second half of the year Conference call begins at 4:30 p.m. Eastern time today BOCA […]
Sensus Healthcare to Host First Quarter 2023 Financial Results and Business Update Conference Call on Wednesday, May 3, 2023
BOCA RATON, Fla. , April 25, 2023 — Sensus Healthcare, Inc. (Nasdaq: SRTS), a medical device company specializing in highly effective, non-invasive treatments for both oncological and non-oncological conditions, announces that management will hold a conference call on Wednesday, May 3, 2023 at 4:30 p.m. Eastern time to discuss the financial results for the first […]
Sensus Healthcare to Host First Quarter 2023 Financial Results and Business Update Conference Call on Wednesday, May 3, 2023
BOCA RATON, Fla. , April 25, 2023 — Sensus Healthcare, Inc. (Nasdaq: SRTS), a medical device company specializing in highly effective, non-invasive treatments for both oncological and non-oncological conditions, announces that management will hold a conference call on Wednesday, May 3, 2023 at 4:30 p.m. Eastern time to discuss the financial results for the first […]
Sensus Healthcare announces the Sensus Cloud™; Unveils New Features at American Academy of Dermatology (AAD) Annual Meeting in New Orleans March 17-19
New comprehensive asset and EMR management feature allows users to collect real-time information from the device to manage and maintain multiple machines with Chat GPT BOCA RATON, FL, March 16, 2023 — Sensus Healthcare, Inc.(Nasdaq:SRTS), the leading manufacturer of advanced medical devices for non-surgical skin cancer and keloid scar treatment, is proud to announce Sensus […]
